Gains by Translation
Roland Martin from the University of Zurich presents the latest MS research in translation, from basic neuroimmunology to disease modifying therapies.
MS Therapy & Monoclonal Antibodies
MS Journal: One way to optimise MS therapy is to implement personalised or extended interval dosing, and monoclonal antibodies are suitable candidates for both.
Susana-Otero Romero from the MS Center of Catalonia (Cemcat) summarises vaccination recommendations in a soon-to-be published EAN/ECTRIMS initiative.